Article:58
- Home
- Profiles
Video Visit Available
Mount Sinai Doctors
Video Visit AvailableAlice C Levine, MD
Endocrine, Diabetes and Bone Diseases (Endocrinology)
Department of Medicine-Endocrinology
212-241-3422
- About Me
- Clinical Focus
- Video
- Education & Certifications
- Research
- Locations
- Insurance
- Publications
- Patient Experience Rating
- Industry Relationships
About Me
Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Dr. Alice Levine has been a faculty member of the Mount Sinai School of Medicine since 1986 when she completed her Fellowship in Endocrinology and Metabolism. She divides her time between clinical, teaching and research activities. Her clinical interests are diseases of the adrenal, pituitary and reproductive glands with an emphasis on hormone-dependent neoplasias. She publishes extensively in these fields. She is the Course Director for the Second Year Medical School Endocrine Pathophysiology Course and is often cited as one of the outstanding Faculty Teachers by Medical Students, Residents and Fellows. In her role as the Program Director of the Endocrine Fellowship, she mentors students, trainees and faculty in clinical and basic science research.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
Clinical Focus
- Acromegaly
- Addison's Disease
- Adrenal Crisis
- Adrenal Incidentaloma
- Adrenocortical Carcinoma
- Congenital Adrenal Hyperplasia
- Cushing's Syndrome
- Galactorrhea
- Pheochromocytoma
Show More
- Acromegaly
- Addison's Disease
- Adrenal Crisis
- Adrenal Incidentaloma
- Adrenocortical Carcinoma
- Congenital Adrenal Hyperplasia
- Cushing's Syndrome
- Galactorrhea
- Pheochromocytoma
- Pituitary Adenoma
- Pituitary Cyst
- Pituitary Tumor
Video
Education
MD, Columbia University College of Physicians & Surgeons
Internship, Internal Medicine
Manhattan VA Hospital
Residency, Internal Medicine
Manhattan VA Hospital
Fellowship, Endocrinology
The Mount Sinai Hospital
Certifications
American Board of Endocrinology
American Board of Internal Medicine
Research
Interactive roles of androgens and growth factors in human
prostate development and neoplasia
Dr. Levine’s Research Laboratory focuses on understanding how hormones and growth factors coordinately regulate prostate growth in order to develop new treatment strategies for men with prostatic disorders. Co-directed by Dr. Alexander Kirschenbaum, Clinical Associate Professor of Urology, her group was the first to publish on the successful management of benign prostatic hyperplasia with hormonal therapy. They also reported that androgens increase stromal cell growth in the prostate and also regulate the powerful angiogenic factor, vascular endothelial cell growth factor (VEGF). Dr. Levine’s group were also among the first to determine the cell-specific expression of cyclooxygenase-2 (COX-2) in the human prostate and to report that selective COX-2 inhibitors kill prostate cancer cells in vitro and in vivo. They established the role of COX-2 in hypoxia mediated upregulation of survival and angiogenic proteins in human prostate cancer cells. Dr. Levine’s group recently isolated and characterized a protein derived from dietary bitter melon seeds that selectively kills pre-neoplastic and neoplastic prostate cancer cells. Her group has also published extensively on the mechanisms underlying prostate cancer bone metastases and developed a bone-targeting compound aimed at preventing and treating prostate cancer bone metastases.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- Department of Medicine-Endocrinology5 East 98th Street, 3rd Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- AgeWell New York
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
- Fidelis Health Care
- HealthFirst Medicare
- Hotel Trades
- Magnacare-Health Care
- Medicare
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oxford - Freedom & Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Community Care Medicaid
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- WellCare Health Plan
- Neurosurgery5 E 98th Street, 7th Floor, New York, NY, 10029
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- AgeWell New York
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
- Fidelis Health Care
- HealthFirst Medicare
- Hotel Trades
- Magnacare-Health Care
- Medicare
- Metroplus
- Multiplan PHCS
- NY Medicaid
- Oxford - Freedom & Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Community Care Medicaid
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Review Article:5
Comment/Debate:3
Letter:4
Editorial:3
Chapter:3
Recent Artifacts
- The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome
- Management of 3 Cases of Pheochromocytoma during the COVID-19 Pandemic in New York City: Lessons Learned
- American association of clinical endocrinology disease state clinical review on the evaluation and management of adrenocortical carcinoma in an adult: A practical approach
- The resilient child: Sex-steroid hormones and COVID-19 incidence in pediatric patients
- Androgen signaling in metastatic bone disease
- Mifepristone treatment for mild autonomous cortisol secretion due to adrenal adenomas: A pilot study
- Mechanisms of osteoblastic bone metastasis in prostate cancer: Role of prostatic acid phosphatase
- Small-molecule activators of protein phosphatas 2A for the treatment of castration-resistant prostate cancer
- Adrenal cushing’s syndrome: Updates on overt and mild hypercortisolism
- Preface
Patient Experience Rating
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
5 out of 5
Care Provider’s Concern
5 out of 5
Likelihood to Recommend Care Provider
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Levine during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- HRA Pharma
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.